Patents Assigned to Insys Therapeutics, Inc.
  • Sublingual fentanyl spray and methods of treating pain
    Patent number: 8835460
    Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
    Type: Grant
    Filed: May 15, 2013
    Date of Patent: September 16, 2014
    Assignee: Insys Therapeutics, Inc.
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran, Neha Parikh
  • Sublingual fentanyl spray
    Patent number: 8835459
    Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable sale thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
    Type: Grant
    Filed: May 15, 2013
    Date of Patent: September 16, 2014
    Assignee: Insys Therapeutics, Inc.
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran, Neha Parikh
  • Manufacturing and packaging room temperature stable dronabinol capsules
    Patent number: 8741341
    Abstract: The invention provides a method of manufacturing and packaging a room temperature stable cannabinoid dosage in an oil-based carrier, wherein the method employs the use of blister packaging and an inert gas atmosphere during blister packaging. The invention also provides a room temperature stable cannabinoid dosage prepared by the methods of the invention.
    Type: Grant
    Filed: March 20, 2013
    Date of Patent: June 3, 2014
    Assignee: INSYS Therapeutics, Inc.
    Inventors: Venkat Goskonda, Ashok Chavan, Kiran Amancha, Scott Crisman, Crystal Lopez
  • ORAL CANNABINOID FORMULATIONS
    Publication number: 20140100269
    Abstract: Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.
    Type: Application
    Filed: October 4, 2012
    Publication date: April 10, 2014
    Applicant: INSYS THERAPEUTICS, INC.
    Inventors: Venkat R. Goskonda, Ashok Chavan, Amit Kokate, Howard Gill
  • Room-temperature stable dronabinol formulations
    Patent number: 8628796
    Abstract: A room temperature stable cannabinoid formulation is disclosed. In preferred embodiments, the cannabinoid formulation is dronabinol in an oil-based carrier contained within a hard gelatin capsule.
    Type: Grant
    Filed: December 9, 2005
    Date of Patent: January 14, 2014
    Assignee: Insys Therapeutics, Inc.
    Inventors: S. George Kottayil, Zhongyuan Zhu, Venkat R. Goskonda
  • SUBLINGUAL FENTANYL SPRAY
    Publication number: 20130327321
    Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
    Type: Application
    Filed: May 15, 2013
    Publication date: December 12, 2013
    Applicant: Insys Therapeutics, Inc.
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran, Neha Parikh
  • Manufacturing and Packaging Room Temperature Stable Dronabinol Capsules
    Publication number: 20130296415
    Abstract: The invention provides a method of manufacturing and packaging a room temperature stable cannabinoid dosage in an oil-based carrier, wherein the method employs the use of blister packaging and an inert gas atmosphere during blister packaging. The invention also provides a room temperature stable cannabinoid dosage prepared by the methods of the invention.
    Type: Application
    Filed: March 20, 2013
    Publication date: November 7, 2013
    Applicant: Insys Therapeutics, Inc.
    Inventors: Venkat Goskonda, Ashok Chavan, Kiran Amancha, Scott Crisman, Crystal Lopez
  • Sublingual fentanyl spray
    Patent number: 8486972
    Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
    Type: Grant
    Filed: January 25, 2007
    Date of Patent: July 16, 2013
    Assignee: Insys Therapeutics, Inc.
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Neha Parikh, Linet Kattookaran
  • Sublingual fentanyl spray
    Patent number: 8486973
    Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
    Type: Grant
    Filed: August 1, 2008
    Date of Patent: July 16, 2013
    Assignee: Insys Therapeutics, Inc.
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran, Neha Parikh
  • Liquid cannabinoid formulations
    Patent number: 8222292
    Abstract: Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.
    Type: Grant
    Filed: August 31, 2011
    Date of Patent: July 17, 2012
    Assignee: Insys Therapeutics, Inc.
    Inventors: Venkat R. Goskonda, Ashok Chavan, Amit Kokate, Howard Gill
  • Oral cannabinnoid liquid formulations and methods of treatment
    Publication number: 20090181080
    Abstract: A room temperature stable aqueous cannabinoid formulation is disclosed. In preferred embodiments, the cannabinoid formulation comprises dronabinol in a mixture of buffer solution, and organic cosolvents such as ethanol, propylene glycol and polyethylene glycol.
    Type: Application
    Filed: August 6, 2008
    Publication date: July 16, 2009
    Applicant: Insys Therapeutics Inc.
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran
  • Sublingual fentanyl spray
    Publication number: 20090176834
    Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
    Type: Application
    Filed: August 1, 2008
    Publication date: July 9, 2009
    Applicant: Insys Therapeutics Inc.
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran, Neha Parikh
  • Aqueous dronabinol formulations
    Publication number: 20080112895
    Abstract: A room temperature stable aqueous cannabinoid formulation is disclosed. In preferred embodiments, the cannabinoid formulation comprises dronabinol in a mixture of buffer solution, and organic cosolvents such as ethanol, propylene glycol and polyethylene glycol.
    Type: Application
    Filed: August 6, 2007
    Publication date: May 15, 2008
    Applicant: Insys Therapeutics Inc.
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran
  • Sublingual fentanyl spray
    Publication number: 20070261695
    Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
    Type: Application
    Filed: January 25, 2007
    Publication date: November 15, 2007
    Applicant: Insys Therapeutics, Inc.
    Inventors: S. Kottayil, Venkat Goskonda, Zhongyuan Zhu, Linet Kattookaran, Neha Parikh
  • Room-temperature stable dronabinol formulations
    Publication number: 20060160888
    Abstract: A room temperature stable cannabinoid formulation is disclosed. In preferred embodiments, the cannabinoid formulation is dronabinol in an oil-based carrier contained within a hard gelatin capsule.
    Type: Application
    Filed: December 9, 2005
    Publication date: July 20, 2006
    Applicant: Insys Therapeutics, Inc.
    Inventors: S. Kottayil, Zhongyuan Zhu, Venkat Goskonda